Kearny Venture Partners logo

Kearny Venture Partners

North America, California, United States, San Francisco

Description

Kearny Venture Partners is a venture capital firm that focuses its investments on healthcare companies that produces novel therapies.

Investor Profile

Kearny Venture Partners has made 27 investments, with 1 in the past 12 months and 7% as lead.

Stage Focus

  • Series C (33%)
  • Series B (19%)
  • Post Ipo Equity (11%)
  • Series Unknown (11%)
  • Series A (11%)
  • Series D (7%)
  • Series E (4%)
  • Debt Financing (4%)

Country Focus

  • United States (93%)
  • Canada (7%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical Device
  • Manufacturing
  • Health Diagnostics
  • Therapeutics
  • Pharmaceutical
  • Medical
  • Clinical Trials
  • Mental Health
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kearny Venture Partners frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 11
Athenian Venture Partners
North America, Florida, United States, Fort Lauderdale
Co-Investments: 5
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 6
New Enterprise Associates
North America, California, United States, Menlo Park
Co-Investments: 6
MPM Capital
North America, Massachusetts, United States, Boston
Co-Investments: 5
Triathlon Medical Venture Partners
North America, Ohio, United States, Cincinnati
Co-Investments: 6
Venture Investors
North America, Wisconsin, United States, Madison
Co-Investments: 6
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 7
Delphi Ventures
North America, California, United States, San Mateo
Co-Investments: 5
Aisling Capital
North America, New York, United States, New York
Co-Investments: 8

What are some of recent deals done by Kearny Venture Partners?

Elektrofi

Boston, Massachusetts, United States

Elektrofi is a preclinical-stage company dedicated to redefining the standard of drug delivery by transforming the patient experience.

Alternative MedicineBiotechnologyTherapeutics
Series CAug 22, 2024
Amount Raised: $112,250,000
Cybin

Toronto, Ontario, Canada

Cybin is a biopharmaceutical company that develops psychedelic therapeutics for mental health conditions.

BiotechnologyHealth CareMental HealthPharmaceutical
Series BJul 1, 2020
Amount Raised: $33,104,739
Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series UnknownMar 16, 2017
Amount Raised: $40,000,000
ViewRay

Oakwood, Ohio, United States

ViewRay is a medical company that develops radiation therapy technology for the treatment of cancer.

BiotechnologyHealth CareManufacturingMedical Device
Post Ipo EquityJan 18, 2017
Amount Raised: $26,100,000
ViewRay

Oakwood, Ohio, United States

ViewRay is a medical company that develops radiation therapy technology for the treatment of cancer.

BiotechnologyHealth CareManufacturingMedical Device
Post Ipo EquityAug 22, 2016
Amount Raised: $14,000,000
ViewRay

Oakwood, Ohio, United States

ViewRay is a medical company that develops radiation therapy technology for the treatment of cancer.

BiotechnologyHealth CareManufacturingMedical Device
Post Ipo EquityJul 24, 2015
Amount Raised: $26,700,000
Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series CApr 23, 2014
Amount Raised: $22,000,000
ViewRay

Oakwood, Ohio, United States

ViewRay is a medical company that develops radiation therapy technology for the treatment of cancer.

BiotechnologyHealth CareManufacturingMedical Device
Series UnknownDec 17, 2013
Amount Raised: $30,000,000
TriVascular

Santa Rosa, California, United States

TriVascular develops new medical devices providing optimal solutions for endovascular aortic repair (EVAR).

Health CareHealth DiagnosticsMedical Device
Series ENov 18, 2013
Amount Raised: $40,000,000
Aerpio Pharmaceuticals

Cincinnati, Ohio, United States

Aerpio Pharmaceuticals is a biotechnology company that develops small molecules and monoclonal antibodies for vascular diseases treatment.

BiotechnologyHealth CareTherapeutics
Series ANov 6, 2013
Amount Raised: $36,000,000